SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-446683
Filing Date
2012-11-01
Accepted
2012-11-01 16:37:15
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d410265d10q.htm 10-Q 646541
2 LOGISTICS AGREEMENT, DATED SEPTEMBER 1, 2012 d410265dex104.htm EX-10.4 680440
3 SECTION 302 CEO CERTIFICATION d410265dex311.htm EX-31.1 7680
4 SECTION 302 CFO CERTIFICATION d410265dex312.htm EX-31.2 7906
5 SECTION 906 CEO AND CFO CERTIFICATION d410265dex32.htm EX-32 7370
  Complete submission text file 0001193125-12-446683.txt   3924845

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctic-20120930.xml EX-101.INS 300798
7 XBRL TAXONOMY EXTENSION SCHEMA ctic-20120930.xsd EX-101.SCH 38811
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctic-20120930_cal.xml EX-101.CAL 47516
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctic-20120930_def.xml EX-101.DEF 198028
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctic-20120930_lab.xml EX-101.LAB 285053
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctic-20120930_pre.xml EX-101.PRE 231088
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12465 | Film No.: 121174004
SIC: 2834 Pharmaceutical Preparations